When you see headlines that look like this is from last year, Pfizer says COVID-19 vaccine

shows 100% efficacy in adolescents.

There's your first question.

When Pfizer says in 100% efficacy, those should send alarm bells and say, wait a minute,

I remember this segment about the science, I maybe should question this.

And even the FDA, listen to this, this was a press release on the back of that when they

authorized their Pfizer shot, their COVID-19 Pfizer shot for emergency use in adolescents.

And part of the data they use, the efficacy data to show this thing is really effective

at that time.

They say this, the immune response, that's basically just the antibodies generated, just

an immune response, we generate some antibodies to the vaccine in 190 participants 12 through

15 years of age was compared to the immune response, some other antibodies of 170 participants,

16 through 25 years of age.

So they compare them.

They just said, this looks like that.

Therefore, let's put it in tens of millions of people, kids.

In this analysis, the immune response of adolescents was not inferior to at least as good as the

antibody immune response of the older participants.

And for people that are joining us, just brand new here, this is something I know when

we hear antibodies, we think, oh, it means we're immune.

It truly does not.

There's all sorts of different antibodies.

...